Sei Investments Co. Boosts Stake in West Pharmaceutical Services, Inc. (NYSE:WST)

Sei Investments Co. increased its holdings in West Pharmaceutical Services, Inc. (NYSE:WST) by 12.7% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 401,026 shares of the medical instruments supplier’s stock after purchasing an additional 45,208 shares during the quarter. Sei Investments Co.’s holdings in West Pharmaceutical Services were worth $132,095,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of WST. Pacer Advisors Inc. lifted its position in shares of West Pharmaceutical Services by 17.9% during the 2nd quarter. Pacer Advisors Inc. now owns 8,574 shares of the medical instruments supplier’s stock valued at $2,824,000 after buying an additional 1,303 shares in the last quarter. Skandinaviska Enskilda Banken AB publ raised its position in West Pharmaceutical Services by 9.8% during the second quarter. Skandinaviska Enskilda Banken AB publ now owns 15,629 shares of the medical instruments supplier’s stock worth $5,148,000 after acquiring an additional 1,401 shares during the period. Bridges Investment Management Inc. purchased a new position in West Pharmaceutical Services during the second quarter valued at $205,000. Canada Pension Plan Investment Board grew its position in shares of West Pharmaceutical Services by 25.0% in the second quarter. Canada Pension Plan Investment Board now owns 207,564 shares of the medical instruments supplier’s stock valued at $68,370,000 after purchasing an additional 41,454 shares during the period. Finally, Davidson Capital Management Inc. raised its position in shares of West Pharmaceutical Services by 34.1% during the 2nd quarter. Davidson Capital Management Inc. now owns 8,926 shares of the medical instruments supplier’s stock worth $2,940,000 after purchasing an additional 2,272 shares during the last quarter. Hedge funds and other institutional investors own 93.90% of the company’s stock.

West Pharmaceutical Services Trading Down 1.0 %

Shares of West Pharmaceutical Services stock opened at $308.15 on Friday. West Pharmaceutical Services, Inc. has a twelve month low of $265.00 and a twelve month high of $413.70. The firm’s 50-day moving average price is $303.67 and its 200 day moving average price is $337.77. The company has a current ratio of 2.34, a quick ratio of 1.68 and a debt-to-equity ratio of 0.03. The firm has a market capitalization of $22.45 billion, a PE ratio of 40.65, a P/E/G ratio of 10.58 and a beta of 1.01.

West Pharmaceutical Services (NYSE:WST) last posted its quarterly earnings data on Thursday, July 25th. The medical instruments supplier reported $1.52 EPS for the quarter, missing the consensus estimate of $1.74 by ($0.22). West Pharmaceutical Services had a net margin of 18.25% and a return on equity of 19.17%. The firm had revenue of $702.10 million during the quarter, compared to analyst estimates of $729.36 million. During the same period in the prior year, the company posted $2.11 earnings per share. The firm’s revenue for the quarter was down 6.9% compared to the same quarter last year. On average, sell-side analysts predict that West Pharmaceutical Services, Inc. will post 6.42 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, VP Charles Witherspoon sold 1,029 shares of the business’s stock in a transaction that occurred on Monday, August 19th. The stock was sold at an average price of $300.00, for a total transaction of $308,700.00. Following the transaction, the vice president now directly owns 1,478 shares in the company, valued at approximately $443,400. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Corporate insiders own 0.53% of the company’s stock.

West Pharmaceutical Services Profile

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.